🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Online now for the #AACR25 session on Advances in #KRAS Biology in PDAC by session speaker Andrew Aguirre: Response and Resistance to RAS inhibition in Cancer brnw.ch/21wSgTw

Key resistance data in patients with #PancreaticCancer receiving PanKRASi Daraxonrasib. By Andrew Aguirre #AACR25 - Amplification of mutant KRAS allele under selection pressure in 1/3rd pts on progression. - No secondary KRAS alterations - Multiple alterations in RAS pathway

Thursday is the next Comp #IO Webinar! Exploratory surrogate endpoints & CDX are transforming clinical trial design in IO, crucial for advancing personalized #medicine. Speakers: Janice M. Mehnert, MD, Rui Sammi Tang, PhD, Julie Rytlewski, PhD. Register: sitcancer.org/CompIO

New study from ARTNet ARTI U54 center MD Anderson Cancer Center, published in Cancer Cell, reveals that radiotherapy induces cuproptosis—a copper-dependent cell death—in cancer cells, independent of apoptosis and ferroptosis. This discovery opens avenues for enhancing radiotherapy

🎉 The 2025 National Cancer Institute #CAPITSummit is coming! 🗓️ Agenda is live & public registration is now open. 🔗 Explore the program & sign up today via the CAP-IT web portal: ncicapit.org/en/cap-it-summ…

Epstein–Barr virus-mediated immune evasion in tumor promotion dlvr.it/TKdrB1

Online Now: Immune evolution in pre-invasive lung adenocarcinoma dlvr.it/TKfLSX

A Proffered Abstract at #AACR25 : New from the Human Tumor Atlas Network: Multi-modal profiling of HR+ metastatic breast cancer reveals tumor-intrinsic and microenvironmental programs driving CDK4/6 inhibitor resistance. Largest spatially resolved MBC cohort to date.

Join the Childhood Cancer Data Jamboree this September 29–30! Hosted by National Cancer Institute, this event invites researchers to explore datasets/tools to tackle scientific questions in childhood cancer. Register & submit project abstracts by June 23: events.cancer.gov/nci/ods-data-j…

The Lessons from the CIMAC CIDC Network webinar will explore how machine learning-driven modeling of multimodal data can be used to profile patient #heterogeneity and analyze diverse #immunotherapy treatments. Register for this #SITC #NCI webinar for FREE: sitcancer.org/CompIO

New study reveals that disrupting translation fidelity in tumor cells boosts their immunogenicity. TYW2 knockout triggers aberrant peptides, enhancing T cell response and sensitivity to PD-1 blockade - a novel path to cancer immunotherapy. #CancerResearch #Immunotherapy

Excited to share our recent nature paper! nature.com/articles/s4158… Tremendous collaborative effort from UChicagoCancerCenter The University of Chicago University of Chicago Radiation Oncology Ralph Weichselbaum

CASE REPORT Histological transformation of non-small-cell lung cancer: A neglected entity journals.lww.com/cancerjournal/…

Recent studies suggest that therapy resistance correlates with distinct acute myeloid leukemia subsets and that the differentiation status of leukemia cells affects sensitivity to BCL-2 inhibition. ow.ly/OVYy50VXkPq #myeloidneoplasia

New study decodes resistance to ICIs in NSCLC using plasma proteomics. Insights into personalized therapy & drug targets from 388 resistance-associated proteins (RAPs).

🎉The #ARTNet roadmap article is now out in Nature Reviews Cancer: Acquired resistance in cancer: towards targeted therapeutic strategies. Kudos to former Functional Screens & Assays WG chairs Drs. Alice Soragni (Soragni:Lab, UCLA) & Erik Knudsen (Roswell Park), and all WG members

New #JITC article: Dual roles of IRE1α inhibition in reversing mitochondrial ROS-induced CD8+ T-cell senescence and exerting direct antitumor effects in multiple myeloma bit.ly/3Zau68t

🚨Roadmap 🚨 Alice Soragni Soragni:Lab, Erik S. Knudsen Roswell Park & Co discuss the mechanisms of acquired resistance and the models to better study it to advance predictive and proactive prevention in cancer therapy. 📖 ⬇️ bit.ly/3Hv6qpj